Towards patient-based cancer therapeutics.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20829823.
- Also identified by DOI 10.1038/nbt0910-904 and PMC identifier 2939009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A new approach to the discovery of cancer therapeutics is emerging that begins with the cancer patient. Genomic analysis of primary tumors is providing an unprecedented molecular characterization of the disease. The next step requires relating the genetic features of cancers to acquired gene and pathway dependencies and identifying small-molecule therapeutics that target them.
Medical subject headings
- Antineoplastic Agents
- Neoplasms
- Precision Medicine